PCI is a respected industry leader and trusted partner providing a comprehensive range of outsourced pharmaceutical services from early stage development to long term commercial supply
Speed, Quality & Cost - Why you should be conducting your Clinical Trials in Australia...
NOVEMBER 13th 2018 - 4PM EST (NA). 9PM GMT (UK). 8AM AEDT (AUS)
Rapid ethics approval and a simple notification to the Therapeutic Goods Administrations (TGA) means that from submission to FPFD it will only take on average 6 weeks. Coupled with the attractive R&D tax incentive program...
PCI Pharma Services is pleased to announce the completion of our acquisition of Sherpa Clinical Packaging (Sherpa)...
Sherpa’s packaging, labeling, distribution, temperature-controlled storage and returns services are highly complementary to PCI and adding this key geography further strengthens our ability to support existing and new customers.
PCI has launched a new Webflow App and it's available now
Webflow is a market leading technology providing a comprehensive customer support portal which brings many benefits to our clients including access to a wide range of reports updated in real time and available 24/7, enabling more efficient and effective supply management.
Core services include: Analytical services, formulation development, clinical trial services, commercial manufacturing and packaging, QP services, supply chain management, storage and distribution. Customers may choose to use us as a complete development partner and benefit from our full range of services or choose any of our core services as a stand-alone offering.
PCI is pleased to announce the completion of a dedicated Returns Management facility at our Clinical Services Center of Excellence at Bridgend, in the UK. The development reinforces our ongoing investment in and expansion of our global Clinical Services network, reflecting our long-term commitment to ensuring successful Clinical study outcomes for clients
Sherpa’s packaging, labeling, distribution, temperature-controlled storage and returns services are highly complementary to PCI and adding this key geography further strengthens our ability to support existing and new customers.
PCI is pleased to announce the completion of a purpose built -40°C storage and distribution facility at our North American Clinical Services Center of Excellence.
Mr. Haffar joins PCI with over 22 years of experience in the pharmaceutical industry, and currently serves as President of Aptar Pharma and a member of AptarGroup’s senior executive committee.
PCI Pharma Services is pleased to announce the installation and validation of our latest comprehensive Serialization system, located at our manufacturing Center of Excellence in Tredegar, UK.
PCI Welcomes Mark Shepanski as the Site Lead of San Diego Facility
PCI looks to Shepanski to assume leadership role at San Diego Center of Excellence PCI is pleased to announce the... View Article
Significant Milestone Achieved – 80 Serialization Installations Across Our Global Supply Network
We’ve extended our industry leading position for product security for global medicines with significant Serialization and Anticounterfeiting technology investment We... View Article
.@Xtalks - It's happening tomorrow and it will be very interesting! Register here bit.ly/2zBJcqU… twitter.com/i/web/status/10620…
x
